Catalyst Pharmaceutical Partners Aktie
21,34
EUR
+0,62
EUR
+2,99
%
24,78
USD
+1,01
USD
+4,25
%
Werbung
Catalyst Pharmaceutical Partners Aktie Analyse
| 21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
| 30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
| 14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
| 29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |
Werbung
Werbung